This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
This article contains content that is written like an advertisement. Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view.(April 2012) (Learn how and when to remove this message)
A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page.(May 2016) (Learn how and when to remove this message)
(Learn how and when to remove this message)
Biocon Limited
Headquarters at Electronic City, Bangalore
Company type
Public
Traded as
BSE: 532523 NSE: BIOCON
ISIN
INE376G01013
Industry
Biopharmaceutical
Founded
1978 (46 years ago) (1978)
Founder
Kiran Mazumdar-Shaw
Headquarters
Bangalore, Karnataka
,
India
Key people
Kiran Mazumdar-Shaw (Executive Chairperson)
Peter Bains (Group CEO)
Siddharth Mittal (CEO & Managing Director)
Shreehas P Tambe (CEO & Managing Director, Biocon Biologics Limited)
Products
Biologics
Small molecules
Branded formulations
Research services
Revenue
₹15,621 crore (US$2.0 billion) (FY24)[1]
Operating income
₹4,195 crore (US$530 million) (FY24)[1]
Net income
₹1,030 crore (US$130 million) (FY24)[1]
Total assets
₹52,044 crore (US$6.5 billion) (2023)[2]
Total equity
₹22,489 crore (US$2.8 billion) (2023)[2]
Number of employees
16,545 (March 2023)[3]
Subsidiaries
Biocon Biologics
Syngene International
Website
www.biocon.com
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978.[4] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries,[5] including the United States and Europe.[4] It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.[6]
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy and nephrology products. Some of Biocon's key brands in India include INSUGEN (rh-insulin), BASALOG (Glargine), BIOMAb EGFR (Nimotuzumab), BLISTO (Glimepiride + Metformin), CANMAb (Trastuzumab), Evertor (Everolimus), TACROGRAF (Tacrolimus), ALZUMAb (Itolizumab) and KRABEVA (Bevacizumab).[4]
Syngene International Limited (Syngene) is a publicly listed subsidiary of Biocon, operating in the contract research and development organization.[4]
^ abc"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr". Biocon. 16 May 2024. Retrieved 17 May 2024.
^ abcdCite error: The named reference ref1 was invoked but never defined (see the help page).
^"Active Pharmaceutical Ingredient (API)". Biocon. 3 July 2020. Retrieved 26 December 2022.
^"Review for "Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin‐R with the US ‐licensed Humulin® R formulation in healthy subjects: Results from the RHINE ‐1 (Recombinant Human INsulin Equivalence‐1) study"". 29 September 2021. doi:10.1111/dom.14635/v1/review2. {{cite journal}}: Cite journal requires |journal= (help)
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic...
Biocon Hebbagodi (formerly known as Hebbagodi) is an upcoming elevated metro station on the Yellow Line of the Namma Metro serving the Hebbagodi suburb...
protected area coverage. Biological Conservation 169: 100–108. doi:10.1016/j.biocon.2013.10.014 Jackman Bauer (2008). Global diversity of lizards in freshwater...
Biological Conservation. 257: 109070. Bibcode:2021BCons.25709070M. doi:10.1016/j.biocon.2021.109070. S2CID 234841035. Archived (PDF) from the original on 2023-01-17...
Conservation. 168: 128–133. Bibcode:2013BCons.168..128O. doi:10.1016/j.biocon.2013.09.024. hdl:11250/2492589. Kristoffer T. Everatt; Jennifer F. Moore;...
including main campuses of Infosys, Wipro, TCS, HCL, Tech Mahindra and Biocon. Electronic City was the brainchild of R. K. Baliga, the first Chairman...
Biological Conservation. 184: 18–26. Bibcode:2015BCons.184...18R. doi:10.1016/j.biocon.2014.12.024. Carter, N. H.; Shrestha, B. K.; Karki, J. B.; Pradhan, N. M...
Conservation. 127 (2): 158–166. Bibcode:2006BCons.127..158F. doi:10.1016/j.biocon.2005.08.006. Waldbauer, Gilbert (2006). A Walk Around the Pond: Insects...
venture capital funding for biotechnology in the country – $8 million. Biocon, headquartered in Bangalore, is the nation's leading biotechnology company...
Biological Conservation. 159: 80–87. Bibcode:2013BCons.159...80Z. doi:10.1016/j.biocon.2012.11.007. Emmons, L. H. (1987). "Comparative feeding ecology of fields...
Biological Conservation. 232: 8–27. Bibcode:2019BCons.232....8S. doi:10.1016/j.biocon.2019.01.020. Saunders, Manu (16 February 2019). "Insectageddon is a great...
Biological Conservation. 206: 47–55. Bibcode:2017BCons.206...47A. doi:10.1016/j.biocon.2016.12.011. Archived (PDF) from the original on 8 July 2022. Retrieved...
Conservation. 203 (203): 1–7. Bibcode:2016BCons.203....1J. doi:10.1016/j.biocon.2016.08.034. Archived from the original (PDF) on 2021-05-19. Retrieved 2019-05-24...
Conservation. 126 (2): 216–233. Bibcode:2005BCons.126..216K. doi:10.1016/j.biocon.2005.05.011. "The Guano War of 1865–1866". World History at KMLA. Retrieved...
home to around 47% of the 265 biotechnology companies in India, including Biocon, India's largest biotechnology company, giving Bangalore the nickname of...
Biological Conservation. 217: 11–27. Bibcode:2018BCons.217...11A. doi:10.1016/j.biocon.2017.10.010. S2CID 90834034. Archived from the original on 2019-02-23. Retrieved...
Conservation. 168: 128–133. Bibcode:2013BCons.168..128O. doi:10.1016/j.biocon.2013.09.024. hdl:11250/2492589. Pimm, S. L.; Lawton, J. H. (1978). "On feeding...
Global Information
₹15,621 crore (US$2.0 billion) (FY24)[1]